Orasure Technologies Inc Receivables Turnover Ratio (OSUR), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Orasure Technologies Inc  (NASDAQ: OSUR)
 

Orasure Technologies Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Orasure Technologies Inc's ability to collect accounts receivable sequentially worsen to 4.62, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Average collection period, for Orasure Technologies Inc's accounts receivable remained unchanged at 79 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 413 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2424 to 2820.

What is Receivable Turnover Ratio?
What is Orasure Technologies Inc Selling?


What is Receivable Turnover Ratio?





OSUR Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change -1.17 % 15.3 % -6.77 % -9.85 % -32.02 %
Y / Y Revenue Change -1.93 % -5.1 % -30.6 % -31.48 % -41.81 %
Receivable Turnover Ratio (TTM) 4.62 4.63 4.86 5.27 5.63
OSUR's Total Ranking # 2820 # 2424 # 1811 # 2292 #
Accounts Receivable average collection period days 79 79 75 69 65
Seq. Receivable Change 3.18 % 11.73 % -8.63 % -6.18 % 20.38 %
Seq. Revenue Change 10.2 % 3.89 % -0.03 % -14.31 % 6.63 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 153
Healthcare Sector # 414
Overall Market # 2820

Receivable Turnover Ratio Statistics
High Average Low
7.7 6.05 4.3
(Sep 30 2014)   (Jun 30 2026)






Financial Statements
Orasure Technologies Inc's Accounts Receivable $ 26 Millions Visit OSUR's Balance sheet
Orasure Technologies Inc's Sales TTM $ 112 Millions Visit OSUR's Income Statement
Sources of OSUR's Revenues Visit OSUR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OSUR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OSUR's Growth Rates OSUR's Roa OSUR's Inventory Turnover Ratio OSUR's Dividend Comparisons
OSUR's Profitability Ratios OSUR's Roi OSUR's Asset Turnover Ratio OSUR's Dividend Growth
OSUR's Valuation Ratios OSUR's Roe OSUR's Financial Strength Ratios OSUR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Milestone Scientific Inc   11.82 $ 8.855  Millions$ 0.749  Millions
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Premier Air Charter Holdings Inc   10.66 $ 31.562  Millions$ 2.961  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Lifeloc Technologies Inc   10.48 $ 9.269  Millions$ 0.884  Millions
Irhythm Holdings Inc   10.32 $ 825.702  Millions$ 80.007  Millions
Immucell Corporation  10.29 $ 29.777  Millions$ 2.893  Millions
Addus Homecare Corp  10.23 $ 1,475.610  Millions$ 144.195  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Radnet Inc   10.11 $ 2,268.932  Millions$ 224.447  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Lensar Inc   9.75 $ 60.264  Millions$ 6.184  Millions
Biolife Solutions Inc   9.67 $ 102.718  Millions$ 10.626  Millions
Encompass Health Corporation  9.57 $ 6,206.100  Millions$ 648.325  Millions
The Oncology Institute Inc   9.57 $ 587.244  Millions$ 61.364  Millions
Alumis inc   9.44 $ 7.398  Millions$ 0.784  Millions
Enanta Pharmaceuticals Inc  9.29 $ 65.258  Millions$ 7.027  Millions
Neuronetics Inc   9.24 $ 154.594  Millions$ 16.732  Millions
Harmony Biosciences Holdings inc   9.22 $ 960.191  Millions$ 104.164  Millions
Pavmed Inc   9.16 $ 0.126  Millions$ 0.014  Millions
Ardent Health Inc   9.16 $ 6,405.940  Millions$ 699.363  Millions
The Pennant Group Inc   9.15 $ 1,101.710  Millions$ 120.457  Millions
Lexicon Pharmaceuticals Inc   9.14 $ 41.469  Millions$ 4.535  Millions

Date modified: 2026-08-14T20:50:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.